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The multiplicities of a modest innovation: the 
introduction of a monitoring technology for asthma 
treatment in primary care 
By Henriette Langstrup Nielsen, Ph.D. student, Copenhagen Business School, hln.ioa@cbs.dk 
 
Introduction  
“Since May this year it has been possible for asthmatics to be have a diary 
concerning their illness on astma-allergi.net. Astma-allergi.net is established in 
cooperation with the Asthma-Allergy Foundation and the pharmaceutical company 
AstraZeneca. Using the new dialogue-function, the data of the patient can become 
accessible to his or her doctor – that is if both parties agree to this. […] 
- AstraZeneca, who are behind this new innovative dialogue-function, has 
developed the system in cooperation with Danish physicians. This has been 
done out of a wish to offer doctors and patients a new tool for asthma 
treatment. The dialogue-function is a possibility for doctors and patients to be 
able to work with a web-based tool in the monitoring and treatment of a 
chronic illness like asthma, says Henrik Nistrup, director of sales and marketing 
in AstraZeneca. 
- Fundamentally it is about transferring knowledge between patient and doctor in 
a way that is as quick and as efficient as possible. The patient can let the doctor 
follow his condition. On his side, the doctor can get quick and precise 
knowledge about the state of the patient and give advice and treat in relation to 
this. […]” 
(Press statement from AstraZeneca, 2000) 
 
This text will be concerned with the introduction of a tool for the online monitoring of 
asthma in primary care in Denmark. As indicated above the tool is presented as an 
innovation in asthma treatment that unites several interest and promise to help reach a 
shared goal of better treatment of asthma. The main innovative feature is the possibility to 
connect patients and doctors – primarily GPs – and make data on asthma accessible via the 
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Internet, but also to add to the quality of treatment by processing these data using state-of-
the-art treatment principles, that have been incorporated into the tool. As such the patients 
will be able to receive instant messages in relation to the data they enter, telling them how 
their asthma is doing and how to adjust their medication accordingly – by taking more 
medication or by consulting a physician. In relation to the GP, he or she has the possibility 
to use the accessible data to calculate the appropriate level of treatment using a function for 
calculating the individual patients control-status – that is seeing if the level of treatment is 
optimal in relation to the current symptoms of the patient. This functionality is based on an 
algorithm, which uses what specialists often refer to as “the golden standard” of asthma 
treatment as its model – GINA-Guidelines (Global Initative for Asthma). 
 
This tool is presented as an innovation that can incorporate many different actors – patients 
and doctors, pharmaceutical industry, a patient organization, specialists on asthma – and 
make them come together in relation to a common goal of providing better asthma care. 
And it did seem to be a promising tool that is in accordance with many of the resent moves 
toward improving healthcare: It is patient-centered, giving the patient a tool to become a 
better informed and more active/responsible agent in relation to his or her illness; it is based 
on state-of-the-art guidelines, and is in that sense following the initiatives toward EBM 
and quality improvement, by being a tool for more standardized and scientifically informed 
medical practice; and it is to help efficiency in the clinical work of doctors, by making the 
appropriate information accessible on demand and by making the necessary calculations 
automatic.     
 
However, this isn’t the story of sweeping success. Though the Internet site and 
functionalities are still up and running and more GPs as well as other healthcare 
professionals are still in the process of being enrolled through training courses given by the 
pharmaceutical company, it has been very difficult to transform these promising visions into 
new medical practices in primary care.  
 
In this text I will address the rather simple question of why this seemingly self-evident 
innovation fails becoming the expected huge success in primary care, when it seemed to be 
able knit together otherwise distant or divergent agent and interest, and in doing so making 
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the shared goal of better asthma treatment within reach. Different actors in relation to this 
case do have different answers to this question. My aim is to answer the question by trying 
to follow the path of introduction and implementation as experienced by a number of GPs, 
who tried to install the monitoring tool into their practice in 2001 and 20021. The answer 
offered through this way of analyzing the events, has to do with a seeming mismatch 
between the practice that was inscribed into the technology and the actual practice in which 
it was to be inserted. While it seemed possible initially to perform this technology as both an 
innovative system and a modest one, in that it only optimized and automated what was 
already agreed upon to be the way of doing things, it seemed to change character when 
confronted with the everyday life of primary care. In this case, a technology that promised to 
make issues surrounding asthma easier to handle actually seemed to make them the more 
difficult: In trying to bind together different locations of the performance of asthma by use 
of ICT, the multiplicity of the object, rather than a singularity is brought to the fore leaving 
the GPs with more work of coordination than they started up with. The work of 
implementation demanded among other things that GPs had to open up otherwise black-
boxed routines and entities, such as the diagnosis, the organization of initiative, the 
appropriate zone of medical intervention and the distribution of medical agency. While the 
systems protagonists might argue that this overspill of multiplicity and differences where 
standardization and singularity was sought is just a proof that the work in primary care is 
flawed with idiosyncrasies and in a state even worse that they would have thought, I would 
like to make a slightly different argument. Instead I will argue that it is only and specifically 
by introducing this “modest” technology into primary care that the entities on which it is 
being founded seem to multiply, become reconfigured and therefore demand even more 
radical changes in how to work with asthma, than ever imagined by the GPs involved.  
 
Annemarie Mol has made a related point in her argument that the performance of disease as 
a singular entity often depends on the distribution of differences to different (socio-
materially embedded) localities, separated by time and space (Mol, 2003). Conflict between 
the different ways a disease is being performed in these different local circumstances she 
argues, is often avoided precisely because of this distribution. Subsequently it might only be 
                                                 
1 I have conducted semi-structured interviews with 6 different GPs and have done field observations at the 
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in trying to coordinate between the different local performances of a disease that such 
difference come to the fore and therefore become problematic. In the present case, an 
insistence on one shared reality of asthma in practices of both science, industry, primary care 
and patients lives, which is stated as an already defined fact, in practice turns out to be a 
huge task of work of enrollment, translation and alignment of entities to be able to end up 
with asthma as a well-coordinated, “singular” object (Latour, 1987). However, the singularity 
is not the result and rather than unifying interests and goals, the GPs – precisely because 
they are equipped with this technology that bring other locations and agents into being – 
come to doubt such unity and rather see multiple orders, goals and interests arise. This lack 
of coherence is not outside of the “object” of asthma, but part of the way it is being 
performed in these particular instances, with this particular technology. Berg has suggested, a 
given materialized order, such as a medical protocol or the tool addressed in this case, seem 
to create or bring along its own disorder when taken into use (Berg, 1998). Disorders that 
might overflow the way in which the technology was just intended to fulfill a specific, 
modest function (Latour, 2002). It is in this vocabulary of Actor-Network Theory and 
related approaches to the study of medicine and technology that I will now turn to the case 
of asthma monitoring.  
 
A win-win-situation 
 
“Bronchial asthma is a disease with high frequency and considerable morbidity 
despite of very good options in relation to treatment.” 
 (From the consensus rapport “Diagnostics and treatment of bronchial asthma in 
adults” published by the Danish Medical Association, 2002) 
 
“The increase in the number of people being affected by allergies [here seen to 
cover both asthma, eczema, hay fever and other disease related to hypersensitivity] 
has to be brought down. The progression of the disease and complications should 
be prevented among other things through self care-initiatives.” 
(From the strategic rapport “Sund hele livet” published by the Danish Government, 
2002)  
 
                                                                                                                                                 
courses given for GPs at the pharmaceutical company.   
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Asthma and allergy related illnesses have, together with other chronic diseases, that affect 
large numbers of people over long periods of time, been given much attention in the last few 
years from policymakers as well as from the medical profession in Denmark. Asthma in 
particular is by some said to affect some 5% of the adult Danish population (when drawing 
on self rapport in health surveys (Mosbech, 1999)), while others refer to a group of 340.000 
(= 6.8%) asthmatics, (when including the ones that have not yet been diagnosed and 
therefore are unaware and untreated (AstraZeneca, internal rapport, 2000)). Every year 
somewhere between 120 and 250 persons die from asthma (Mosbech, ibid.). In 2000 the 
expenses used in Denmark for purchasing asthma medication for adults amounted to 
approximately 755 million Danish crowns or 101 million euros (The Danish Government, 
2002). Furthermore policymakers point to the costs related to absence from work and 
school due to illness, as a major source of expenses for businesses and the public sector 
alike. Lastly, the failure to provide adequate treatment or motivate patients to follow such 
treatment – which is already seen as being easy accessible in the form of acute and 
preventive medication – has negative consequences in relation to peoples quality of life, in 
that the disease might inhibit their daily lives and also prevent them from engaging in 
otherwise healthy activities (such as being physically active). The attention that has been 
raised around asthma have primarily focused on ways to improve the treatment that is 
provided in particular by general practitioners, who see and prescribe treatment for most 
cases of asthma. Only the more severe cases of asthma are handled by specialists or in 
outpatient hospital clinics.  
The general practitioners have been pictured as both the main obstacle and the main vehicle 
to reach goals of improving the treatment of asthmatics. The obstacle relates to the generally 
acknowledged difficulties related to get GPs to follow the standardized and scientifically 
supported protocols developed and supported by both international and national experts in 
various fields of treatment, that is also in relation to asthma. However the problem of “non-
compliant” GPs is often related to another though highly related problem – that of non-
compliant patients. The general notion – as stated in the literature on compliance (i.e. Sackett 
& Haynes, 1976) - is that one should not expect that any more than 50% of the medication 
prescribed would actually be taken. GPs, being the ones with the most contact over time to 
the public in health related matters, are being presented in the medical literature and 
guidelines as being of outmost importance, not just in prescribing the best possible 
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treatment for people with asthma, but also in educating and motivating these patients to 
abide to the treatment-plans given, that is complying. In practice compliance in relation to 
state of the art asthma treatment means that people should not just take their medication 
when feeling an asthma attack occurring, but also taking preventive medication in periods 
when they are feeling good, making the necessary changes in lifestyle and regularly seeing 
their GP for adjustments in their treatment.  
 
For the pharmaceutical companies that are involved in developing and producing asthma 
medication such issues are of course of outmost importance. The multinational 
pharmaceutical company AstraZeneca (AZ) has the major marked share on selling asthma 
medication in Denmark. They are in different ways involved in urging both GPs and patients 
to become more compliant with “the ratio-pharmaceutical regimen of asthma care” as 
represented in the guidelines that promises health benefits through the continuous use of 
both preventive and acute medication for the chronically ill asthma patient.  
 
But also other voices related to asthma care are arguing for more standardized treatment and 
closer monitoring of compliance and treatment results. As we saw in the quotes above, 
political as well as professional bodies are trying to intervene trough initiatives that promote 
both standardization of the medical interventions and better compliance of patients through 
“self-care initiatives”. Also the Danish patient interest group on asthma, the Asthma and 
Allergy Foundation, argues for better and more standardized treatment plans and better 
education and information for patients to be able to take the responsibility of their own 
treatment.  
 
Seen in this light, asthma care isn’t an arena for big controversies between interest groups, 
and positive responses were also abound when AZ in 2001 launched an internet site on 
asthma and allergy with a central feature that made it possible for asthma patients to monitor 
their asthma on-line getting immediate responses on the state of their asthma and making it 
possible for their GP to access their asthma data and use this to optimize their clinical 
decision-making also by using and on-line professional tool. From the beginning it had been 
possible to make the Asthma and Allergy Foundation a partner in the development of the 
site and leading medical specialists in the area supported the development of its 
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functionalities. In the following I will start by presenting a short description of the 
functionalities of astma-allergi.net/linkmedica2, and in particular the monitoring tool that 
was to change asthma treatment in primary care. Following this, I will set the scene of the 
analysis by introducing the broader lines in the development and distribution of linkmedica. 
However, to get into the practices of primary care, I will leave the “big” story of innovation 
rather quickly to engage in the more subtle challenges met by GPs in trying to change their 
ways of working with asthma.    
                                 
The case  
In this section I will present Linkmedica and the functionalities of the monitoring tool.  
The Internet site is defined broadly as concerned with asthma and allergies, and it provides 
users with a long list of functionalities in relation to these topics. Most are related to 
information on the illnesses and their treatment, and are made accessible in a knowledge 
center. Here it is also possible to post questions to a list of (primarily medical) experts within 
this field. Another area is related to debate - the forum -and it is possible to contribute to a 
number of different themes on asthma and allergies. The last area, and that which I will 
primarily be concerned with, is the asthma control area, that is focused on asthma in 
particular and which holds the possibility of connecting people with asthma with their health 
care providers.  All these functions are accessible free of charge for everyone with access to 
the Internet.  
To use the control center you have to submit as an asthmatic user or as a professional user. 
The asthmatic user can create his/her own user-profile on the site alone or assisted by 
his/her physician. The professional users may already be registered in advance as the site 
uses a publicly accessible database with all the registered GPs in the country to update its list 
over physicians. Professional users who are not already registered on this list (specialists, 
(asthma) nurses, secretaries or newly established GPs), may be so through the AZ, who is 
managing the site and the control center. The professional user may be provided with a 
personal password either by participating in one of the courses on “Asthma and the 
Internet” that AZ provide or on request. The two kinds of users – asthmatics and 
                                                 
2 The site changed its name in 2001 to linkmedica following a strategic turn toward internationalization. I will 
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professionals – can become related through a process, where the asthmatic user chooses his 
own GP from the list available at the site, and the GP accepts this user to his patient list in 
his part of the system.  
The two parts of the system are also different in their functionality. The non-professional 
part for the asthmatic user provides a diary in which data related to asthma symptoms (I will 
come back to these in more detail below) are to be entered on a daily basis. The asthmatic 
user will receive a computer-generated massage related to these data, accessing whether the 
asthma is under control or in exacerbation and suggesting how to adjust the current 
treatment. The data will be represented to the asthmatic user as a diary – every day 
represented in peak flow values3, a color related to the state of the asthma (green = in 
control, yellow = exacerbation, red = danger) and as a curve that is to show the 
development of the symptoms over time. 
From the patient’s asthma diary: “Enter your asthma values”. In the lower right 
corner the colors indicate the asthma status during the last month. White squares 
indicate that no data has been entered. (Nov. 2002) 
 
                                                                                                                                                 
use this name for the remaining part of the text.   
3 Peak flow is a value to be read off a small device called a peak flow meter to measure your own lung capacity 
by blowing hard into a tube. The blow will move an indicator and the value that can be read then is your peak 
flow. 
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The professional part of the site has a “patient list” that presents the user with all the 
asthmatic patients of his that have chosen this particular professional as “primary 
physician/nurse”. (S)he then has to accept the person as user to get access to his/her data. 
In the patient list, it is possible for the professional to see the current color code related to 
the data of the individual patients and by clicking on their name, the professional will be 
represented with a more detailed overview of the person’s latest entries, much like what the 
non-professional user himself is represented with. But furthermore, the professional part of 
the system has a decision-support application that makes it possible not only – as that of the 
patient – to give advice related to the day-to-day entries, but also to make calculations on the 
available data over a larger period of time to regulate the overall treatment plan. The system 
will – if asked to – calculated how the patient is doing on a number of parameters related to 
the data being entered daily and evaluate if the patient should be moved up or down in 
relation to six different steps of treatment. These steps are developed in accordance with 
international guidelines for the treatment of asthma (GINA4), even though these guidelines 
only operate four steps of severity of asthma and different treatment related to these four 
steps. 
From the professionals “overview” of one particular patient (Nov. 2002) 
                                                 
4 Global INitiativ for Asthma 
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Presently 400 Danish GPs have registered as users of the on-line asthma control center since 
the possibility was first launched in the fall of 2000. The number of registered patient-users 
is approximately 7500. However, it is only possible to document 200 unique users (that is 
both professionals and patients) logging on each week5. In relation to this it is important to 
note, that the system is also used in relation to some ongoing studies that involve 
somewhere between 100 and 150 research subjects.    
 
Performing GPs as data processors with capacity 
problems (Towards a singularity of asthma treatment) 
“The doctor can use Linkmedica to automatically do the otherwise burdensome and 
time-consuming calculations, which are necessary as to give the correct treatment 
following current international guidelines on asthma treatment. In this way routine 
the asthma patient’s follow-ups are made easier and the time in the consultation is 
used more efficiently”. 
(From the GPs’ user manual, 2002) 
 
In what follows I will show how Linkmedica and in particular the monitoring tool are 
presented to GPs as modest technology. Technology that can make the work that they are 
already doing much easier, but apart from this won’t change the content of the work 
radically. But what this work actually is, how asthma is “done” in practice, might not be a 
given. Instead the relationship between what is easy and what is troublesome becomes 
reconstructed locally. Here the monitoring tool participates in performing asthma treatment 
as a difficult task for which help is needed. The disorder that is being argued – the non-
existing compliance with GINA guidelines – seems strangely enough unable to exist without 
the aimed-at order already being a part of current practice. The goal is thus not only located 
in some promising future, but also seems to become installed in the present in such a way, 
that the technology is only a modest means to further an already existing development and 
aspiration which unfortunately finds itself limited by practical hindrances. The developers of 
Linkmedica and the monitoring tool seem to acknowledge that it might not be sufficient just 
 12
arguing that GINA is the way to “do asthma” and that what the GPs are currently doing, 
might not only be incorrect but even worse irrational, idiosyncratic and in opposition to 
authoritarian knowledge. For GINA-guidelines to become the measuring pole by which 
order and disorder is defined it – or at least the norm of standardized and science based 
treatment – has to be made an internal part of the existing practice. If this tool is to make it 
easier to treat asthma, it has to be difficult to start with – that is easy and difficult related to 
in pursuing the goal of complying with “current international guidelines on asthma 
treatment”.  
 
In one of the courses being given to GPs in using Linkmedica and the monitoring tool, it 
seems possible to establish this already existing order of rational GPs, complying with 
guidelines as far as possible. In this reality disorder – that is limited access to patients’ data, 
lack of time and capacity – becomes something possible to address effectively using the 
monitoring tool. GINA and the monitoring tool become in this particular instance active 
participants in performing the work of the GPs as both defined both by order and disorder 
– thus making a modest intervention possible. 
 
Using different kinds of advertising, GPs, practice nurses and secretaries have been invited 
to participate in one of the courses on the subject of “Internet and Asthma” which the 
pharmaceutical company have been giving since the launch of Linkmedica and the associated 
monitoring tool. The courses have now been running for a couple of years and in the 
beginning in particular it was very much framed to be the future users who were to be 
central as active participants in adjusting and improving the tool. The participants were 
encouraged to give feedback to the designers and developers and a user group was formed.  
 
The following field note relates to observations made at one such course, where JA 
introduces a group of PGs and practice nurses to the monitoring tool. He is a medical 
doctor and has done research on asthma. Currently he is working for the pharmaceutical 
company and is in charge of the medical part of Linkmedica – that is primarily the 
monitoring tool.  
                                                                                                                                                 
5 Personal message from e-business manager, AZ, May 2003. 
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JA starts a presentation of the nature of asthma – he asks the participants to bear 
over with him, as he is quite sure that they know all of it in advance. The reason to 
tell it anyway is to ensure that they understand how the system is constructed. It is 
structured around the on-line diary of a patient and JA wants to make it clear that 
this actually isn’t all that different from the paper diary that the patients usually use. 
There are some parameters in relation to which the patient is supposed to enter 
data. A part from this the patient has to indicate who her GP is and then the GP is 
supposed to log on. JA: “This is just an asthma diary on the Internet – it is what we 
usually do, just made easier!”    
 
In relation to the courses the practices of the GPs are not depicted as being flawed with 
idiosyncrasies. Rather Linkmedica and in particular the monitoring tool is presented as in 
concordance with current practices and as possible to adjust further to become fitted for 
practice. The knowledge and the practice of treating asthma that this tool is representing is 
said not to be different from what is to be found in the everyday work of the present GPs 
and nurses. This is the practice of informed and skilled professionals – a group that JA also 
performs himself as part of by talking of “we” in relation to what is usually done. And as JA 
is making himself part of their practice, he is also making them - or at least inviting them to 
become – part of his practice of system development, by asking them to give feedback and 
join a user group. The tool is said to represent the work and at the same time optimizing it 
by using the Internet. The Internet is here presupposed to be a (“natural” and 
unproblematic) part of medical work. Furthermore the asthma diary6 isn’t introduced but is 
suggested to be something already part of the way the “we”- that is all medical professionals 
– treat asthma. It is a performance of a shared medical expertise and also rather uniform 
practice of asthma treatment that is here being done. Furthermore, asthma and its treatment 
is presented as something primarily concerned with the collection of patient data using 
standardized parameters and where the access to these data are of crucial importance to the 
treatment. Also this points to the patient as playing an important role as producers of such 
                                                 
6 An asthma diary is a sort of logbook, which is given to a patient together with a peak flow meter (a simple 
device to measure lung capacity at home). The patient is supposed to measure her peak flow value once or 
several times a day for a period of time or continuously and enter these values into the often preprinted grid of 
the diary. Such a diary will often be give to the patient in relation to making a diagnosis (using the diary as a 
tool to access the variability of the symptoms over time as well as the effect of the medication), as an 
educational tool to improve the patients understanding of her own illness, to ensure compliance with the 
ordered treatment regime or/and as a more continuous collection of asthma values to be used at follow-ups to 
adjust the treatment.      
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data, though the introduction of this agent and the practice of monitoring at home doesn’t 
seem to introduce less coherency to the object of asthma – quite the opposite.        
 
Asthma – JA tells the participants – is characterized as a variable disease. If it didn’t 
vary – not only among patients but also inside a patient’s trajectory – then there 
would be no need to monitor. But because it varies, it should be monitored. No one 
permanent treatment can be given. Its intensity has to be adjusted.  
Then he shows a matrix with all the parameters and different levels of severity – he 
tell us that this is “the golden standard” in relation to asthma diagnostics and 
treatment: GINA-guidelines. At the bottom it says: www.ginaasthma.com. “When 
you make a decision about treatment, it’s because this staircase is in your heads – 
isn’t it?” No one really answers. JA goes through the model: Peak flow, symptoms 
during the day, and symptoms during the night. Then he asks the participants to 
solve a problem: JA has his own patient that he has been using as a guinea pig – L. 
The participants are asked to judge the severity of L’s asthma and related level of 
treatment. Everyone is given a paper with fourteen day of diary registrations from 
L’s diary. Furthermore they are given GINA-guidelines on a piece of paper, which 
also states the algorithm needed to calculate the level of treatment. They have to 
calculate total use of acute medication, number of days with symptoms (night, rest, 
activity), lowest peak flow and peak flow variability in the period. JA says that this 
test is given with the cunning intention of showing to them how difficult it really is 
using these tools and how much easier it is using the monitoring tool. “It is what 
they expect us to do – the big wigs” – he points to the algorithm. 
 
 GINA guidelines, which the tool is based on and which were previously presented as the 
provider of order and uniformity when applied though the use of the tool, are here made 
synonymous to the GPs own cognitive processes. The staircase-model of GINA, which 
divides asthma cases after severity and prescribes a variable level of treatment in relation 
hereto, is indicated as already being part of the way the GPs treat their patients, even if only 
indirectly inside their “heads”. At the same time the practical work of treatment is 
introduced into the course through the small exercise, where the participants are asked to 
use these guidelines to categorize and suggest treatment for a patient. JA is very clear in 
stating the intention behind the exercise – showing to the GPs that they are in need of help, 
because it is such a difficult task to solve. In this particular situation the limitations of the 
GPs rationality are not given in advance. The GPs are being performed as data processors 
with capacity problems, is rather the result of solving the problem of L’s treatment. As the 
GPs (some of the nurses assist, but most of the GPs are doing the calculations alone) engage 
in the task and start calculating this becomes a difficult and bothersome task to solve 
without a computer or a calculator assisting in processing the data automatically. To make 
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something seem easy it first has to be difficult, to be able to create order, there have to be a 
state of disorder. As stated by the expert, who is also medically responsible for Linkmedica: 
 
“…[it] is very, very difficult to improve something, when you as a GP is of the 
conviction that everything is fine. Then you have to stir up a lot of prejudices and a 
lot of preconceptions related to the notion that what you are already doing is really 
all right and then explain, that it isn’t. That in and of itself is a big job.” 
(Interview, 2002) 
 
In this local performance of asthma treatment as a difficult medical task, GINA comes forth 
as being an obvious and unquestioned golden standard. But such an order has to be 
produced and ensured through much activity. If it weren’t possible to depict asthma diaries 
and (GINA) guidelines as already being part of the current work practice, it would be quite 
difficult to introduce the monitoring tool as a modest technology, which nevertheless will 
make the work with asthma easier. All of these rationalizing tools, which are supposed to 
adding more science, efficiency and effectiveness to the treatment of asthma, bringing 
together otherwise distant and disconnected actors, are not just producing this envisioned 
order, but are at the same time, through their very existence, making it possible to identify 
“the other” – the disorder to be eradicated (Berg, 1998).  
The inclination to want to use the tool is thus made felt by the participants on their own 
bodies struggling with the algorithm, but also strengthen further by referring to “the big 
wigs” – whether these are medical authorities or policymakers isn’t indicated. But their 
authority and legitimacy to impose standards onto practitioners seems unquestioned.  
 
To sum up, I have just argued that apart from just introducing a new possible way of treating 
asthma, which includes using some very specific computer-supported tools, JA also 
performs the current work practice as one having particular work routines, particular tools, a 
particular division of labor and subscribing to a particular set of moral prescriptions. In this 
work practice the GP and the patients use a peak flow meter and an asthma diary for home 
measurements making it possible for the GP to access the necessary data for calculations. 
The GP will see her or his patients on a regular basis, making it possible to get descriptions 
on symptoms and also guidelines are supposed to be used to categorize the illness and 
prescribe a treatment regime in relation hereto. The diagnosis in itself seems unproblematic 
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in this description that mainly puts the variability to the fore as demanding special attention. 
Getting access to the correct data and therefore to the patient becomes a central concern. 
The division of tasks between patients and GP seems thereby given: The GP prescribes the 
patients to monitor and register their asthma data – the GP asses the data and adjusts the 
treatment by using the monitoring tool and its decision-support features7. But answering the 
question of how the patient in the first instance is made accessible for the engagement with 
such monitoring is fare from obvious. The problem of presupposing that patients are already 
accessible to the GPs through diaries and check-ups is that this might not be the case in 
practice.       
The modesty of the tool, I have argued, is dependent on a particular performance of what 
already is, performing asthma, the practices and localities of its treatment and the agents 
related to these practices as all being already aligned though not effectively coordinated and 
linked. The task that remains seem to be this linking up of entities to conclude the work 
toward better asthma care and for this linkmedica is an innovative tool. However, in the 
following I will show that these entities and agents are not already aligned, and that by 
introducing this tool, this order into their practice, the GPs becomes faced with much work 
of reconfiguring their practice to suit this particular order. The tool brings new entities, 
localities and agents into their practice and what might have seemed fairly straightforward – 
among other things because it was distributed to different localities such as the clinic and the 
home – now becomes problematic and multiple. Furthermore the experience of most of 
them is that they cannot make that final link, getting patients to use the monitoring tool and 
they doubt whether they should really make the effort, as the advantages are no longer that 
obvious.  
 
                                                 
7 This is particularly interesting in relation to the way the monitoring tool was initially presented to the public. 
Though with limited success, the Internet site in general and the monitoring device in particular was to begin 
with targeted to patient-users through commercials on health-portals on the web as well as in other media. In 
relation to this marketing strategy the monitoring tool was presented as something primarily of interest to 
people suffering of asthma, who would be able to get automatic advice by using the system. Apart from this 
they could also ask their GPs to “look in on” the data if they wanted them to and if the GP would agree. Only 
later a “professional” tool providing decision-support was presented to GPs, encompassing additional features 
related to the incorporation of the GINA-inspired “stair-model” to asses and adjust treatment over time and 
only to be done by a professional user. As such the initial marketing strategy targeted at patients indicated a 
different division of roles and tasks In asthma treatment: One where the person suffering of asthma is the 
primary person in initiating monitoring assisted by the technology and being the one deciding when and if the 
GP should also have a look at the data.   
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The way I have structured the remaining part of the text, is by following the different steps 
as described to me by the GP in their implementation of the tool in their practice. First I will 
look at the way the GPs worked to construct their local “asthma-population” finding 
themselves embedded in a practice already sociomaterially stipulated in a particular way. 
Second I will attend to the ways in which the introduction of the tool calls on a 
reconfiguration of diagnostic practices unsettling the very category of asthma opening up to 
more differentiated definitions of the category. In relation to this I will also address the 
problem of who has the right to define a medical problem – a question, which also seem to 
be produced through the introduction of the monitoring tool and which touch upon and 
problematizes the role of the GP. Third, I will look at the work of turning patients into self-
monitoring asthma patients and how this brings the specificities of how asthma is done 
outside the medical practice into the clinic, raising question of what might be an appropriate 
zone of medical intervention and the limits of shared interests and common goals.        
 
Performing the population of asthmatics 
To be able to use the monitoring tool the GPs have to have some asthma-patients to treat. 
In the presentation of the tool it is very much taken to be an unambiguous fact that asthma 
patients are part of the work of general practice – that they are “out there”. But this self-
evident entity – the asthma patient – turns out not to be given after all and the use of 
different diagnostic tools, work routines and other situated orders seem to be producing 
asthma patients in different ways. These other tools and practices intended in their own right 
to acquire and produce knowledge and structure medical work are not just a passive toolbox 
to be applied onto “the asthma patient”. Rather such tools participate in producing the very 
phenomenon, that they are to register or order (Mol, 2000). “They intervene in the situations 
in which they are put to use” in rather specific ways, and what counts as an asthma patient, 
how one knows such a person and how one locates her depends on the results of such 
interventions (Ibid. p. 9). Further on we will look into how the monitoring tool intervenes in 
to the relation between GP and patient, but before such intervention is possible first the 
patient must be located using tools already at hand. 
At the course JA asks the participants to tell a bit about the number of asthmatic 
patients in their consultations. The first participant to talk is a male GP, who tells us 
that he has a patient population of 1500 including children. Of these patients 
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approximately 50-60 are asthmatic and of these ¾ are adults. However after having 
come up with this number they have been finding more people with asthma since 
they have started using both new and old diagnostic methods more frequently – that 
is spirometry and pric test. 
One of the other GPs says that he got quite surprised not to find more asthmatics 
among his patients as he was preparing for the course. They only amounted to 20-
30. JA says that it seams as if the asthma patients are taking up too much space in 
his work since he got so surprised that no more turned up. The GP responds that it 
depends what is meant by “asthma”. He argues that the “pure asthma patients” are 
very few and that you only see them rarely. JA asks provokingly if that isn’t just a 
result of them being to ill and that’s why they seem to take up so much time in the 
consultation – that it’s a result of bad treatment. Everyone laughs and the GP under 
accusation denies this to be the case in his practice.   
 
The participants at these courses are often very well prepared when coming to attend. Many 
have taken their time investigating into the number of asthmatic patients in their patient 
population while others relies on a more general impression from their daily experience. 
However the number and the very possibility of “counting heads” seems to be related to 
diagnostic tools and practices and the very definition of asthma. In the account of the first 
GP the number of asthma patients have become higher with new practices, while the second 
GP indicated that he had fewer than he had thought because he put up a criteria of “pure 
asthma” while looking. In his account there are accordingly different kinds of asthma-
patients, some more pure than others.  
Whether preparing for the course or actually taking the monitoring tool into use the GP, the 
nurse or the secretary has to do some work to locate these asthma patients. This work relates 
to the way in which the GP knows the individual patients and how these are registered and 
categorized locally. This again relates to existing sociotechnical practices such as diagnostic 
tools available, recording practices, research file and treatment strategies.  
 
As some of the GPs earlier have participated in clinical research on asthma, they have come 
to know those of their patients that fit the category of “asthmatic” in a very particular way. 
They know (maybe not exclusively but still often related to) these persons treatment in 
relation to the research protocol that has been followed in the study. This means that they 
have been instructing the patients, often seen them regularly over a period of time to collect 
data and finally to deliver or process these data to produce research results. One GP tells 
that he has made himself a file of asthma patients in relation to an earlier study in which he 
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participated and that this work is now paying off in his search for user to the on-line 
monitoring tool. His practice is already stipulated materially by the previous research he had 
done and the way this study had put asthma on the agenda in his work. Now can he – in 
relation to asthma, while not in relation to other illnesses – look up names in the file and 
contact the persons that he wants to. Others have had more trouble localizing possible 
candidates. Even though several at the courses indicates that it is possible for them to do a 
search on asthma in their electronic patient records it seem more difficult than just pushing 
the search button. Primarily because the search function only can be used if the entries have 
been coded in accordance with predefined diagnostic codes and this is often not the case. 
Even if it is, there are sometimes problems using the search function. In these cases it isn’t 
possible to search the free text of the patient record and this will often be the place in which 
a reference to asthma can be found. GPs who don’t have standardized coding practices have 
to resort to other ways of finding the asthma patients of their practice, ways that are often 
somewhat arduous. The following quotes are from interviews with two different GPs.    
 
HLN:  How then was the recruitment organized? 
A: (Laughs) It was a big problem, because it ended up being based on memory. As it 
is now we can’t make a search on who have asthma and who haven’t.  
HLN: You don’t have any diagnostic codes or… 
A: Yes we do, but we are still not able to make a search across the databases. We 
can search in some statistics, but it isn’t something we have really been going 
into. Just searching across databases, that we couldn’t, so we had to use our 
memory.  
HLN: You didn’t have a file or anything? 
A: No, not in particular.  
HLN: Did you then sit down and find them, as they had to come in for check-up 
any way? 
A: No, it was just when they call themselves to get renewed prescriptions to their 
asthma medication. 
(Interview with GP A., 2002) 
 
B: It was kind of uphill work. What we did was the secretary wrote up their names 
when the patients called in to get a renewed prescription to their medication. 
Then we contacted them after having checked that they did in fact have asthma – 
some we contacted over the while others we approached when they came to the 
consultation. 
(Interview with GP. B., 2001)               
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The medication turns out to be an important marker of asthma patients in primary care and 
many of the interviewed GPs used this indicator to find possible users. Moreover this relates 
to the fact that only one of the interviewed GPs had prescheduled check-ups with asthma 
patients (that is this job was mostly delegated to the practice nurses). The most important 
recurring contact between the individual asthma patient and his or her primary care clinic, 
which concerned asthma in particular in most cases, consisted of renewing prescriptions 
(usually over the phone) and consultations where the patients come on their own initiative. 
Answering the question of who was asked to use the monitoring tool, GP C says: 
 
C: It was the asthma patient coming to the clinic. 
HLN: When they came here anyway? Did you already have prescheduled controls 
with your asthma patients? 
C: With some… no, it is more based on need. I don’t have prescheduled controls 
with asthma patients. I don’t do it systematically. Not at all actually. This you will 
find in relation to diabetes and hypertension and pregnancy and things like that. 
They’ll come in at certain times. Asthma patients don’t. Asthma patients come when 
they fell that they have got a problem, which they can bring to the GP. With things 
like that, this is the way it is defined.      
(Interview with GP C., 2001) 
 
The ways in which the GPs already see their (asthma) patients, whether they have regular 
check-ups, how they categorize or code them into their filing systems, which possibilities 
different tools and routines give them to acknowledge someone to be an asthma patient – all 
these things become important participants in making the GP and his staff able to find users 
for the monitoring tool. Furthermore specific work has to be done to establish these 
required asthma identities, that might not have been well defined and separated from other 
things beforehand. Pen and paper have to be ready by the phone, if someone calls for repeat 
prescription, records and files much be searched, patients has to be contacted or approached 
when already at the clinic – work that didn’t have to be done previously and work that will 
often be done by secretaries or nurses.  
The many badly treated asthma patients that research on asthma might point, are not sitting 
in the GPs consultation waiting to be attended to. Rather they have to be produced from the 
material, technological and other organizational entities and routines, which are already 
there, making up the work of the individual clinics. In the present case it is clear, that there is 
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no clear and detached asthma patient, only different local resources that may be mobilized in 
constructing such a relational quality and work to strengthen it further.       
 
Redefining diagnostic practices and indications for treatment  
And then we have the diagnosis – asthma. In an earlier cited quote a GP said that his 
population of asthma patients varied in relation to what is being referred to by using the 
category “asthma”. By saying this he indicated that talking about asthma in general might not 
be specific enough in pointing to particular patients or in setting up inclusion criteria for the 
patients who are to use this monitoring tool. As we have seen different entities in the clinic 
might indicate the existence of asthma in individual patients – diagnostic codes, entries in the 
record, research files and repeat prescription. But even when such possible asthma identities 
have been appointed there may be raised doubt as to what the indicator actually is pointing 
to. If taking the indicator provided by medication, one may run into the problem, that it isn’t 
just “pure asthma patients” that are given asthma medication such as inhalers for acute relief 
in cases of airway spasms (Salbutamol ?).  This acute relief medication can be prescribed with 
out any significant risk even when there is doubt about the precise diagnosis, since it is seen 
as relatively harmless, without severe side effects and since the use is initiated by the patients 
themselves relating to their own experiences of needing and benefiting from the medication. 
When people come to see their GP with complaints that point to asthma, they can’t always 
expect to go trough a thorough process of diagnosis, that is being diagnosed using different 
routine techniques such as spirometry8, reversibility testing9 and prick test10. Some of the 
tools necessary to do these tests are not always present in primary care and the involvement 
                                                 
8 Spirometry or measurement of the lung function involves testing for FEV1, which refers to the force of the 
air that the patient can provide in a short (1 second) forceful expiration and FVC, which refers to the total 
volume of air that the patient can contain. Both measurements are done by letting the patient exhale (either 
quick and forcefully (FEV1) or slowly and completely (FVC)) into a mouthpiece connected to a reading device 
either digital or mechanical. The measurements indicate the size of the airways and the elasticity of the 
surrounding tissue. It is becoming more usual to find a spirometer as a tool within primary care.           
9 Reversibility testing refers to the evaluation of the possible effect of prescribed medication in relation to other 
measurements (FEV1, FVC and peak flow) and is used to diagnose asthma and access the level of severity.  
Airways that are asthmatic are thus expected to react positively to the pharmaceutical treatment given making 
the improvement visible in the above-mentioned measurements.  
10 Prick test is a way to test allergic reaction to a number of suspected substances that might participate in 
provoking asthmatic reactions or making already existing asthma worse. It is administered by forcing small 
amounts of the different allergens into the skin by pricking with a needle. By monitoring possible swelling or 
rashes in relation to the different allergens allergic reactions are then assessed.    
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of these in the diagnostic process will in these cases demand a referral to a lung specialist. 
The indication of asthma might therefore in some cases only be related to the patient’s 
description of symptoms such as breathlessness and coughing, while other GPs might 
combine different techniques and measurements to produce a diagnosis. Patients may also 
have been given the diagnosis many years ago and the current GP isn’t necessary the one 
originally doing the diagnostic work. Most of the GPs interviewed however felt quite 
confident in their diagnostic routines in relation to asthma and didn’t experience a great need 
to optimize their clinical decision-making process. Though some did use the mentioned 
tools no one said that they explicitly followed guidelines by doing calculations on the data 
they produce as to find the level of severity and appropriate level of treatment. Rather they 
estimate being guided by the data and their previous experience. One GP explains his 
approach to diagnosing and treating asthma in this way: 
  
B: People come here with asthma or if people come with symptoms, which point to 
asthma, then we’ll do some examinations that will confirm or dismiss the diagnosis. 
You’d look at the duration of the complaint, whether there is any fever related, if it 
is just right now they are affected and if it might be a lung infection. If they 
experience that it is something recurring then we may send them on to an 
examination of their airways. Using the numbers we get from these test we will then 
possibly come to the diagnosis of asthma. It also depends on the age group, and 
looking at how the medication works.  
HLN: So you use the pharmaceutical intervention to come to a diagnosis? 
B: Yes, if we can register a reasonable improvement in their lung function. What we 
do is, that we give them a peak flow meter to take home and get them to measure 
for 14 days to evaluate the variability. Dependent on the magnitude of this 
variability, we then start up the treatment. We’ll chose to prescribe bronchodilators 
?- long-term and short-term treatment as well. I think that’s it. And then they usually 
come in for a check-up after about a month or so. I guess that it is after this that it 
stagnates. Because then it might be going all right, and they fell fine and as time goes 
by they just renew their medication and somewhere along the way they might just 
quit.  
(Interview with GP B., 2001) 
 
In this clinic the diagnostic process (and with this the construction of the asthma patient) 
takes up to a month and involves different techniques and tools such as lung function 
measurements (spirometry), home measurements with peak flow meter and reversibility 
testing. But after the diagnosis is made and pharmaceutical treatment started up there won’t 
necessarily be regular contacts between GP and patient. It is the person experiencing 
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problems who will initiate the initial contact to the GP and also later in relation to 
exacerbations it is this person, now having become an asthma patient, who calls the GP to 
get an appointment. If they feel well (or just don’t feel too bad, are busy, or don’t want to be 
a burden on their doctor or for any other reason) they won’t go to their GP to have an 
asthma check up. This is what raises the problem of GPs not being able to prevent 
exacerbations, as they are not able to attend to the variability of asthma over time if the 
patients don’t come in regularly. But trying to change this order through the monitoring tool 
some problems are encountered. The first problem is the more practical one of getting in 
contact with potential users, when work is otherwise organized through patients taking the 
initiative of making an appointment. Many GPs are simply not used to looking up their 
patients in this way – as we have already seen – and when they do they may find something 
quite different, from what they suspected. As such the introduction of the monitoring tool 
calls upon the work of redoing diagnosis and re-categorizing patients, not necessarily 
supporting a smooth introduction of the monitoring tool. The second problem is of a more 
principal nature relating to the question of, who has the right to formulate the problems to 
be solved in general practice. This question is being raised by some GPs and I want to show 
how tools and technologies such as the monitoring tool participate in defining the 
distribution of initiative and responsibility in (asthma) treatment.  
 
Redoing relevant diagnoses and identities 
The GPs who have found possible asthma patients to monitor may have to confirm that 
what they are dealing with is in fact asthma – that is something that is variable and possible 
to treat more efficiently through continuous monitoring. As I indicated earlier some of the 
GPs weren’t totally convinced that the markers that they used to locate asthma patients 
actually excluded other and less appropriate identities. It is with the implementation of this 
monitoring tool that it becomes necessary to validate the existence of asthma in particular 
patients, something that isn’t always necessary to start up treatment. This means that what 
might be found while validating the initial indicators using more strict diagnostic approaches 
and terminology might end up being something quite different from asthma excluding rather 
than including some patients as users. These patients might not have been categorized at all 
if it wasn’t for the implementation of this system that establishes a particular order: 
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inclusion-criteria, which demand that asthma is differentiated from other diagnoses. 
However when the GP starts validating these identities and applying more rigid criteria, this 
may also narrow down the scope of possible users, which he though would benefit from the 
on-line treatment.  
 
GP B: In a project like this, if you say that there are some asthma patients that you 
would like to treat and then when they come, you will have to find out whether that 
have been taking there medication and furthermore, if you haven’t been that 
conscious about their disease, then you’ll have to go into it and measure their lung 
function, their peak flow and things like that. In some cases you will find that what 
you are dealing isn’t asthma at all – rather they have COPD [Chronic Obstructive 
Pulmonary Disease], which means “smoker lungs”, too big lungs. This is a 
condition, which you cannot treat using this [monitoring tool], and for which you 
actually can’t get any real medication. But it isn’t “in” to say: “I have ruined my 
lungs by smoking to much”. It is more “in” to say: “I have asthma”. And that is why 
a whole bunch is being excluded, because there isn’t any reversibility to be found. 
You can’t give them this medication and see them get better. So these are not 
asthma patients, and it turned out that I don’t have that many asthma patients and 
that actually surprised me.  
(Interview with GP B, 2001) 
  
This GP has to redo the some of the diagnostic work, which went into producing the 
indicators in his practice that pointed toward certain individual as being asthmatic, as to 
produce “pure asthma patients” that might benefit from using the monitoring tool. But 
rather than just confirming these identities, the intervention changes them, differentiating a 
large number of patients from being asthmatic, identifying them instead as COPD-patients. 
One obvious consequence is that these patients are not eligible users for the asthma-
monitoring tool as control through the adjustment of asthma medication isn’t a realistic goal. 
This GP also suggests that there might be other consequences from producing this more 
precise diagnosis. Talking about what is “in” among the patients as the diagnosis to name 
their pulmonary problems, he presents asthma as the category that patients would rather 
have, because it indicates a condition you are not responsible for having and which might be 
treated successfully with medicine. The differentiation between asthma and COPD brought 
on by this work of re-diagnosing, forces both GP and patient to face up with something 
which haven’t got “easy” (on-line) solutions and which suggests that the patient has 
mistreated his or her own body through smoking, putting it in this irreparable state. This 
identity might be less than desirable for the patient to hold and the differentiation doesn’t 
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provide the (newly) diagnosed COPD-patient any significant new opportunities, just a more 
sinister prognosis. As Leigh Star has written “…part of the public stability of a standardized 
network often involves the private suffering of those who are not standard” (Star, 1991) and 
the production of such “monstrous” identities are not exogenous to the work of making the 
standard itself work. Rather they are byproducts that have to live with this new and 
negatively defined COPD-identity, which does not provide them with new possibilities, but 
which is necessarily identified and excluded to make the monitoring tool do its’ work of 
helping asthmatics11. As the same GP says in relation to his findings of COPD-patients 
rather than asthma-patients: “Then you will have to see how you might be able to help them. 
But in relation to this project, they are not relevant” (Interview with GP B, 2001)12.  
Relating more to the work of the GPs in trying to make the monitoring tool part of their 
practice, the consequence is also that asthma – in this new and sharper definition – is less 
pervasive in their patient population than they initially thought. The GPs simply end up 
having fewer patients that they expect they might help, than they initially thought, making 
the monitoring tool less potent as a means of handling and improving the treatment of a big 
group of patients.    
          
Promotions, problems and responsibilities 
How to go about promoting new ways of treating an illness to relevant patients? We have 
already seen that in relation to this on-line monitoring tool, the GPs have had to know 
where to find the relevant patients using the already existing cues in their practices and 
furthermore some have had to validate these patients’ appropriateness as users in confirming 
the existing of asthma. But apart from the work of inclusion and exclusion, the work of 
promoting new innovative ways of treatment brings on a more general challenge, which 
                                                 
11 I am not pretending to know whether this is a great burden to bear for the individual, who has to give up 
referring to asthma when explaining to others or in their own understanding of their illness. Also it might be 
possible, that GPs will become more knowledgeable about COPD and more animated to find better ways of 
treatment for these cases after having had this experience of a higher prevalence of COPD in what they 
previously thought of as being asthma. But these are mere speculations. The argument presented here only 
relates to the concrete example of how processes of standardization assist in not only producing the identity of 
the user, but also – through reordering of previous ways of construing certain identities – producing non-users, 
at one time defined in relation to and rejected by a particular standard.       
12 In relation to this albeit very contextual “marginalisation” of the COPD-diagnosis it is however relevant to 
mention that 3.400 Danes die every year from the disease where as the number of deaths associated with 
asthma is, as mentioned earlier, approximately 120.   
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relates to defining when something is a medical problem, and something which should be 
treated by a GP.  
As we have seen in the cases presented here, asthma treatment in primary care is often 
organized around the principle that it is the patients that have to take the initiative to get 
their treatment adjusted after having been diagnosed. This doesn’t just relate to asthma 
treatment, but relates to a more general principal in primary care preventing GPs from 
promoting their services to (possible) clients. The Danish legislation on advertisement of 
health services states that any advertisements addressing patients (being it individuals or the 
general public) that have not specifically asked for such information can only contain 
announcement of the professionals name, and other quite formal characteristics of the 
professional and his practice13. As an example it isn’t allowed to indicate particular areas of 
interest that the professional might have such as asthma. However it is legal to advert – 
objectively, factually and adequately - about available techniques for investigation and 
treatment. Some of the interviewed GPs felt uneasy with the way the introduction of the 
monitoring tool first of all meant that they should offer patients this alternative to the usual 
way of treatment and secondly that the practice of using the tool might mean that they 
would be the ones asking the patients to come in for a check-up on the basis of data entered 
into the accessible on-line diary. Relating to the above-presented law, it is difficult to argue 
that GPs, who are addressing patients to ask them to use the monitoring tool, are breaking 
any law. However the interviewed GPs do not comment on the content of the law, but more 
on the principal related to it – that of preventing GPs (and other healthcare providers) from 
advertising with services to enhance their (primarily publicly funded) sale and in that process 
producing an unnecessary high demand for certain services – making the public more self-
perceived ill and dependent on healthcare than they need to be. One GP comments:  
 
GP D: […] And I don’t really know [how it will work] in relation to the public 
health insurance and the payment… It might pose a problem if we start calling the 
patients up if we think they have a bit of fever. 
HLN: How is that? 
                                                 
13 This law (nr. 463, 1997) is currently being challenged by a proposal for a new law regulating the area (Forslag 
til Lov om markedsføring af sundhedsydelser, 2002). This proposal suggest a liberalization of the area, 
providing delivers of health services almost the same possibilities in relation to the marketing of their products 
as is the case in other areas of commerce. The suggesting is now up for a final vote in the Danish parliament, 
but is being met with significant critique from both the current opposition (left-wing parties) and from several 
lobby organizations.    
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GP D: Well, we are not supposed to call up a patient up if we feel like it. We are not 
allowed to do uninvited promotion of our services. It has to be the other way 
around.   
  
The practice of letting the patients have the right to define the existence of a problem that 
should be attended to by a doctor, means that the GP must regard a started treatment to be 
working if the patient do not come back with complaints. The prescription of short-term or 
long-term pharmaceutical treatment or other interventions that are to take place outside the 
clinic in the privacy of the patient’s everyday life makes the supervision of both compliance 
and effect inaccessible to the doctor. The treatment is carried out in a location that the GP 
has no access to making it impossible to intervene or to take responsibility as to what is 
going on in this location. But in introducing the asthma monitoring tool the absence of a 
patient does not count as an indicator of a well-treated patient, and might also introduce a 
distinction between being well-treated and optimally treated. In the following quote two GPs 
are discussing their experiences with the well being of their asthma patients and the reason 
to introduce the monitoring tool. GP D has not been at the Linkmedica course whereas GP 
C has. They have just agreed that they actually don’t see that many patients that are badly 
treated or getting bad flare-ups. Their experience is generally that people know how to 
handle their illness themselves, even if it sometimes means that they don’t get the optimal 
lung function. Also they agree that patients might regulate their behavior to avoid things that 
provoke their asthma rather than keeping the asthma under pharmaceutical control. But 
generally “They know what to do”.  
 
GP D: I think it is all about self-care - to be fully informed about the illness you 
have and what action to take in particular situations.  
HLN: Is the problem then that you do not know what is going on [at home], who 
follows the treatment appropriately and who doesn’t? 
GP D: But we do know! If they weren’t well treated then they would come to us – 
so we know! 
GP C: But I guess it is true to say that we don’t know whether they are as well as 
they can be. We don’t know whether they could do even better, because we don’t se 
them that often.    
(Interview with GP C and GP D, 2001) 
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In the instance where guidelines are to be followed or the monitoring tool is to be used, it 
becomes the responsibility of the GP to point out asthma patients and possibly also to 
address them. The meaning of absent “patients” changes accordingly, making the patient-
initiated visits problematic as a central organizing principal for the treatment of asthma. The 
experience of the patients themselves of feeling “all right”, doesn’t necessarily coincide with 
optimal “asthma control”. Asthma control is defined by GINA-guidelines as being: 
“Minimal (ideally no) chronic symptoms, including nocturnal symptoms; Minimal 
(infrequent) exacerbations; No emergency visits; Minimal (ideally no) use of p.r.n. (as-
needed) β2-agonist; No limitations on activities, including exercise; PEF (peak flow) 
circadian variation of less than 20 %; (Near) normal PEF; and Minimal (or no) adverse 
effects from medicine.” (GINA, 2002). In the monitoring tool this ideal of control is 
translated into two things, in both cases delegating some of the initiative for medical 
intervention to the technology. There is the indication of control as presented to the patient-
users, who after each daily entry of data will receive a color symbol (Green, yellow or red) 
and a written message telling them whether their asthma is currently well treated and under 
control or if they should adjust their medication or go se their doctor. This control-status is 
based on simple parameters using data that relates to the three previous days. The other 
control-status is calculated in relation to 14 days of entries using 6 instead of 3 parameters 
and a more complex algorithm based on GINA. It is only the GP or other health 
professionals that have access to use this tool, which is the decision-support tool of 
Linkmedica. It is in relation to the use of this control-status that the GP may change the 
treatment by changing the level of treatment in accordance with GINA. The patient using 
her part of the system will only be able to regulate numbers of puffs of her already 
prescribed medication when reacting to the colors and messages she receives through her 
computer.  
In the practice, which does not use an on-line monitoring tool for the continuous 
surveillance of asthma-data, self-experienced needs, pre-set half-yearly consultations or 
empty inhalers may prove adequate as ways of bringing people to the clinic, where the GP 
will assess whether treatment should be changed or whether there is a need for some other 
medical intervention. With the monitoring tool the rights of the patient and the GP 
respectively to: 1) formulate a problem, and 2) conclude that it is a problem in need of a 
medical intervention becomes redrawn and redistributed. The formulation of a problem is 
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now on the one hand a job to be handled on a day-to-day basis by the messages generated by 
the algorithm that makes the patients part of the system function – the problem here being 
defined as exacerbation of the asthma or decline in control. These problems will per se be 
cast as medical problems and the medical intervention is prescribed by the message that the 
patient automatically is presented with on her computer screen. On the other hand these 
data and the daily color-coded scores are equally accessible to the GP on his list of patients 
using the monitoring tool. He will here be able to see possible exacerbations as they are 
recorded by the system. Patients getting red alerts telling them to go to the GP or maybe 
even ER, or just a deterioration – many yellow messages indicating ailing control. Also they 
may primarily see lacking values, empty diaries indicated by a white color code and telling 
them that this patient isn’t doing her monitoring. And how to relate to this information? 
When are we dealing with a problem that needs medical intervention? What do the data refer 
to in the life and body of the asthmatic person?  
 
GP D: “The problem is that if they become red and I am sitting in Australia and 
recognizes this 10 o’clock at night, that they are really, really red – what then is my 
responsibility in this? I know something about this person and if this person does 
react… in situations like that, I don’t know what the juridical situation would be. It 
is comparable to a situation where we receive a really bad lab result […] I do not 
want to take the responsibility. […] They are the ones [the patients] who should take 
the responsibility and react if they are feeling bad enough. I will not take any 
consequences of something I see on the Internet.” 
(Interview with GP D, 2001)   
 
The developers behind the tool have suggested that the GPs might do daily “ward rounds” 
on their on-line asthma patient list or have the practice nurses or secretaries do it. However 
it was stressed at the courses that it should be up to the individual GP how often he or she 
would look at the patient list. The imagined juridical problems as speculated upon by the GP 
above, was exorcised by the developers by referring primarily to the statement of informed 
consent, which patient users have to sign, in which it is emphasized that they themselves 
have the responsibility to react appropriately to both the messages received and more 
generally to how they feel and that the use of the system does not substitute traditional 
consultations with their GP. In one of the earlier designs of the patient list however, it was 
possible for the professional user to send e-mail directly from the website to the patient 
(without the patient being able to see the GPs e-mail address when receiving this mail – the 
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system was presented as the sender14). This may be seen as promoting the GPs toward 
approaching – uninvited - patients on basis of their diary entries and as having a 
responsibility in keeping an eye on the day-to-day compliance of the patients. This instant e-
mail possibility was however not to be found in later editions of the patient list making 
intervention in relation to day-to-day indicators more bothersome15 and making the 
suggested “ward-rounds” less relevant if the data presented isn’t meant to inform any 
possible medical intervention by the GP. These different possible ways of relating the fact 
that patient data become accessible to the GP in a different way is however not settled in 
some more specific instruction of the professional users, but is suggested to be agreed upon 
by the individual patient and GP in cooperation. What the GP should be oriented toward is 
rather the long-term control status for which they’ll need the entries of 14 days in order to 
use the decision-support of the tool to regulate the overall treatment plan in accordance with 
GINA. And it is in this instance that the GP can judge whether treatment is optimal, that is 
under control. As the teacher at a course formulates it for GPs in relation to the exercise of 
looking at on-line patient data: ”L [a patient] isn’t doing alright. The reason we can take the 
liberty to say that he isn’t doing alright is because we know he can do even better”. In getting 
access to these data the indication for medical treatment isn’t that people are in a bad 
condition, but rather that they are not meeting their full potentials. The GP isn’t just there to 
heal or sooth the illness, but to do “disease-management” and as such she is more given the 
role of the “life-coach” or consultant, who gives advice on ways to improve the 
performances of individuals, who themselves are in charge of/responsible for executing 
these advice.    
 
Redefining the zone of medical intervention 
A central idea in relation to our case of on-line monitoring - and more generally in 
telemedicine - is that of making the otherwise physically absent patient present through 
                                                 
14 This partial anonymity related to the general worry some GPs have in relation to e-mail that they will get 
spammed with mails from worrying patients if their e-mail address is accessible for the general public. This was 
especially seen as a problem before the current agreement between the public health insurance and the 
Organization of General Practitioners in Denmark (P.L.O.), which now makes it possible to get payment for 
electronic consultations.   
15 That is, having to reveal your e-mail address by using a conventional mail program and yourself filling in the 
patients e-mail address instead of having it done automatically.  
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technological mediation.  The asthma patients in question are to be mediated more or less in 
real time qua their data on the Internet without having to leave the privacy of their own 
homes. This presence is one related to medical intervention more than it is related 
specifically to the intervention of one particular GP. The GP may still have a privileged 
position in relation to such intervention (doing initial diagnostic work, prescribing the 
medicine, initiating treatment regimes and doing the long-term control status calculations), 
but will by no means be the only one prescribing or executing interventions in such a 
distributed network. Being present in this way, patients might be able to avoid having to go 
see their GP face-to-face or call him/her in relation to minor flare-ups in their asthma. They 
might even be able to avoid such flare-ups altogether – maintaining continuous control - by 
following on-line messages and seeing their GP only for an occasional check-up in relation 
to which the control-status can be calculated using the data from the previous period of 
registration. But reaching such aspirations depends on achieving this more or less 
continuous presence via data. The (now identified and validated) asthma patient also has to 
become a user of the on-line monitoring tool. They have to comply with this new delegate of 
their asthma treatment as well as with the ones already in play – their medication and the 
various pieces of advice they have been given. The medical technology of asthma and other 
chronic diseases has already for a long time been percolating into the everyday life of asthma 
patients, changing not only the distribution of initiative and responsibility but also what 
counts as medical work and knowledge (Willems, 1995). In relation to devices used for drug 
inhalation at home, Willems has shown, how these are being inscribed in such a way that 
they can secure proper inhalation technique leaving as little room for wrong usage as 
possible to the human user (Ibid. p. 71-72). They are delegated the responsibility and their 
proper functioning thus becomes of central concern both to the medical professional and 
the user – making the discussion of devices a central theme in the medical intervention into 
asthma.  
What I would like to address here is the work that the GPs have to do to make patients into 
users and how this work of making users also (re)introduces areas outside the clinic as 
medically significant. That is areas related to patients Internet-literacy, Internet-access and 
more generally the lives they lead, which are to be intervened in when becoming users of the 
monitoring tool. Enrolling patients as users brings several things into consideration that 
otherwise might seem irrelevant in terms of the generalized search for standardized and 
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optimized asthma treatment. Even when having narrowed the initial “asthma population” 
down to “pure asthma patients”, these may not be easy to translate into users of a on-line 
monitoring tool, doing self-monitoring and engaging in mediating presence to assist 
continuous medical intervention. It is not that the GPs as humans have to compensate for 
that which the tool can’t handle the messiness of individual peoples lives – it is rather that it 
is by way of this tool that such issues are raised in the first place – trying to purify things 
seems to – at the same time – hybridize them, making them into a new phenomenon, that 
was not there to begin with, as Latour have already pointed out (Latour, 1991).  
 
Compliance is most often taken to be the extent to which the patient follows the advice 
given by the intervening healthcare professional. Another suggestion is presented by Willems 
(following Law, 1986) as a term referring to the existence of durable, though flexible, links 
between different entities (between patient and treatment) that permits long-distance control 
(Willems, 1995). The question of durability is a central one in relation to chronic diseases and 
intervention into the way people handle their disease outside the spatial and temporal realm 
of the clinic have now for some time be considered legitimate medical work – that of 
compliance enhancement (Ibid, p. 125-132). Physicians should be able – using different 
available tools – to motivate and practically enable patients to follow prescribed treatment 
(not unlike the aspiration of the people behind Linkmedica to support the GPs in complying 
with golden standards by enabling them with technology, that is delegated some of the 
responsibility).  
The monitoring tool may tell the GP something about the individual patient’s compliance, it 
may promote more compliance by educating patients about their illness and learning how to 
control it, but it is also something additional, which the patient has to comply with. How in 
practice to connect this tool to patients’ lives concerns the GPs and becomes a task in itself. 
What are those lives in which it is to be inserted? The ability or practical/material 
precondition for using a PC and logging onto the Internet becomes relevant for this 
particular intervention, as does questions related to how busy patients are in their everyday 
life, their possible benefit or loss in doing the monitoring.  
 
GP E: Trying to make this as easy for myself as possible I chose the ones I thought 
would be more compliant, that is responsive. Some having executive positions, and 
some who are well educated, and two young people, who are used to computers. 
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And then I used some time at an asthma check-up – though I actually think the idea 
speaks pretty much for itself – but I used some time at an asthma check-up to 
explain it to them. We had a brochure to give to them and something called a “start-
kit” containing a peak flow meter, so we could push-start them. […] I had some 
initial great expectation about some of these sailors – we have many sailors in our 
practice, Svendborg being a seaport – and I thought that it would be really smart if I 
could be able to manage them while they were at sea.       
(Interview with GP E) 
 
The practice nurse A, who primarily handles the asthma patients in this practice, in 
terms of the use of the monitoring tool and regularly check-ups, has known this 
patient, S, since she was just a girl. Annette tells that, as an active teenager S wasn’t 
really very interested in keeping her treatment. But after getting husband and child, 
she suddenly agrees to use the computer and come in for check-ups. Later, after 
observing the check-up, I ask A and S, how S initially was introduced to the 
possibility of monitoring: 
HLN: Do you remember if you were the one introducing it [Linkmedica] to S? 
A: Yes, it was. 
S: Was it? 
A: Yes, I gave you a brochure to take home – don’t you remember that we were 
talking about you actually being on the Internet on a daily basis? So she got a 
brochure to take home, and then I said, that you should try to log on, if you felt like 
it, and create a user-id and choose me as the professional. Visa versa, I would then 
have to accept being the professional and then it [the system] would inform us, now 
you are on.        
(From observation of Linkmedica-assisted check-up and Interview with nurse A and 
patient S, 2002) 
 
The ways in which this GP or practice nurse knows their patients becomes relevant to the 
introduction of the on-line monitoring tool. The specificities of these lives are used as 
indicators of the relative success of on-line monitoring – for them as well as for the 
GP/practice nurse. They both point to the necessity of constructing durable links to make 
this tool work, and that this is contingent upon the strength and durability of other links 
outside the clinic. Some already existing links may predict whether hooking up to a medical 
regime and a computer are realistic connections to perform and sustain or not. For example 
teenagers who’s lives are not very organized in terms of routines and home life may have a 
difficult time following a strict treatment plan and even more in engaging in continuous 
monitoring, whereas being married and having a child often relates to more routine activities 
and more time at home.  Also the GPs previous experiences with patient’s compliance 
become important, suggesting that these patients are more persistent and trustworthy in their 
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commitment to treatment. This of course makes patients that are already doing what they 
have been told by their GP (and therefore maybe are relatively well treated) more likely to be 
invited to become users (though they may not be the ones with the least control over their 
asthma). This in a way is comparable to the situation of the introduction course of the GPs: 
If the order of the tool, which is to be inserted in to a particular site, is already there, then 
the intervention will be more modest, demand less from the different actors but also become 
the more successful an implementation.    
But the strength of these links to treatment regimes is not only inscribed in people’s 
demographic characteristics or intellectual merits. It is also inscribed in materials – such as 
the inhalation devices previously mentioned or the mere existence of a computer and 
Internet link. Here the GP also uses the trick of strengthening the link through materiality. 
The “start-kit” with a peak flow meter and a brochure is meant to “push-start” the patient to 
become a user of the monitoring tool. It isn’t enough just to talk about the splendor of the 
tool – the GP has to engage in what Law initially called “heterogeneous engineering” – that 
is the manufacturing of material, organizational and human entities in the construction of 
durable connections (Law, 1986). The materialization of the demands of the tool in the 
context of use is a central intervention to ensure that it in fact will be used (Berg, 1998). All 
the little things that a tool presupposes to exist already and on which it is dependent, often 
call on materialization and distribution in their own right. Peak flow meters, written 
information, computers and Internet connections – all these things have to be in place for 
the system to work and the GP has to engage in work to insure this. If the PC and the 
Internet are to become a central delegate in the treatment of asthma, then skills in relation to 
this become relevant to evaluate or even educate for the GP. Not all GPs find such tasks 
legitimate or may find it hard to use the time necessary to address them. 
 
GP E: If you where to be really fair to the system, which I haven’t had the time to 
be – and this is something I am only coming to think of as we are sitting here 
talking now – you should actually buy some time and use it with them [the 
patients]…. [...] maybe talking more concretely about the Internet and things like 
that. Because even though you might ask them at the consultation, “well, you’re 
familiar with using the Internet” and they say “sure” but in reality this might just 
mean that they have send an e-mail once and nothing else. So you don’t really know. 
For some people it might be difficult and they could just sit here [in the 
consultation] and we could fill out the daily status together. That’s how the rest of 
us learned it [the GPs]. I have also been sitting at Astra long ago and gone over it all.       
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Of the GPs I interviewed none had taken very much time to show the patients how to 
actually do the monitoring using the computer. Some took the time creating the user-
account together with the patient (something which is actually meant to be done by the 
patient, as it involves pressing some “accept-buttons” that spells out the distribution of 
responsibility) and browsing through the functionalities of the monitoring tool and the 
community part of the site. Others relied primarily on patients to go home and learn how to 
use the system being assisted by the brochure and their own motivation to get their asthma 
under control.  
Furthermore the GPs are not paid for the time used instructing people using this system – 
When participating in privately funded research that demands instruction or in publicly 
funded projects such as home measurement of blood pressure, the GPs are used to getting a 
financial compensation for the time they use. When introducing this tool to patients as a part 
of general treatment, there is no such compensation.  
 
The GPs seem ambivalent to the task of introducing patients to a tool that also demands 
some kind of instruction in terms of where to click, how to read messages, and specification 
as to what this means in relation to the treatment in general. The GPs want the tool to be 
the tool of the patients, something additional for those who can and will take more 
responsibility, but without adding to many additional tasks to the GP. They want it to be 
self-evident for patients that this is something that will help them. They do not want to push 
patients too hard, on the other hand the GP quoted above sees a parallel in what it took to 
get him to use the tool.     
 
 
The immodesty of modest technology   
Most of the GP I interviewed had difficulties doing all the work necessary to ensure durable 
links between the monitoring tool, their already existing sociomaterial practice, and the 
asthma patients. The work that I have tried to show here, which was done by individual 
GPs, secretaries or nurses, who were engaged in taking the on-line monitoring tool into their 
practice, was experienced by many as being to much hassle. Far from being a modest 
technology ensuring that what is already done just becomes easier, the introduction of the 
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monitoring tool called upon reconfigurations of work, responsibility and asthma in ways that 
exceeded not just their own capacities or those of their patients but which also made them 
more skeptical towards the consequences of this technology. As such the activities otherwise 
just seen as (failed) implementation become local occasions in the individual clinic to 
“reopen” some otherwise implicit routines and (sociomaterially embedded) ways of ordering 
and see them through the optics suggested by the monitoring tool. It is with the tool GPs 
start to formulate “asthma patients” as something particular, differentiating it from other 
identities they might meet, becoming concerned about what they might or might not do 
when they are not coming to the clinic and whether they are “optimally” treated. But it is 
also in working to reconfigure their relation to asthma patients, making patients into self-
monitoring asthma patients and Internet users that some GPs come to lose their interest in 
the tool.  The work to create and ensure the durability of these relations seems too extensive 
held against the possible return – both in relation to their practices and the well being of the 
patients. As one GP comments:  
 
GP E: If you have to push them [patients] all the way and call them up every 
morning and [say]: “Remember to type in [the data]”, then there is no catch in it. 
And if you can’t get an educated person to do it, then who can you?” 
(Interview with GP E, 2001) 
 
In relation to an evaluation study made for the pharmaceutical company a GP suggests that 
there might be a problem in relation to getting patients to understand that this primarily is 
their tool, making it possible for them to get better by avoiding flare-ups and limitations in 
their everyday activities.  
 
“GP: Well, the first steps are always the hardest. I think it was extremely hard. I 
used a lot of time in the beginning, but it has become easier.  
Interviewer: Do you remember what it was that was hard if you look here? 
GP: It was difficult to explain to people in a good way, what it was we wanted, and 
especially to explain to them that in the end they were the ones benefiting from it. 
That it wasn’t just something that would make me happy.” 
(Nielsen, 2002 – my translation)        
  
With these complaints we return to the problem of promotion that I addressed earlier. 
Inscribed into the tool in a particular distribution of interest – primarily assuming that 
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patients and GPs have interests that coincides (which again coincides with the interests of 
the pharmaceutical company) – all want better treatment of asthma. For GPs this might 
mean better results in terms of more control with the outcome of ones professional work 
and for patients more control with ones chronic disease and quality of life. If this were so, 
there would be no need for promotion beyond the reassurance from the GP that this tool 
works to do the job. But as we have seen GPs have to more than just offer this way of 
treatment to patients. They have to interest them, to produce durable relations between the 
clinic and the lives of these persons or, as one GP suggests, “build a narrative in to the 
patient”. A common interest isn’t there in advance, but has to be built on location, 
something that the asthma consultation and the tool don’t seem to afford very easily. This 
becomes paradoxical for many of the GPs, as they primarily see this tool as something, 
which can help patients gain control over their disease, their body and greater independence 
from the intervention of the GP. The GPs feel uncomfortable in promoting it further when 
patients are not responding positively to their initial presentation. The fact that they will be 
following standards, getting their practices more orderly, seems to have become less 
important for most of the GPs at this point. But when patient don’t seem to take up the 
tool, when they are not responding to the offer by complying, then the GPs takes this to be 
lack of “maturity” on the part of the patients (as in taking responsibility for ones own health) 
or the failure of the tool in being able to connect to peoples lives (being too complex, too 
time-consuming). One GP tells me, that he feels that he has got more knowledge on asthma 
from trying to put this tool into use. However, this is knowledge, which as made him more 
skeptical about the order or script of the system, than he had been to begin with. Rather 
than asthma becoming a difficult and important disease to intervene in and therefore calling 
on scientifically informed tools and reconstructions of the relationship between GP and 
patient, the disease has become a more mundane ailment in most cases. By trying to enroll 
people he has become convinced that the interests of the different participants do not 
coincide and the downsides of making them do so are too big. Asthma, he now sees as 
something that people find individual ways to live with, something that isn’t serious or 
threatening enough to monitor continuously to avoid flare-ups and progressive deterioration 
of lung tissue. The way the tool focuses on peak-flow is a central issue in relation to way the 
patients do not continue to use the tool: 
 
 38
GP F: Peak-flow is something, which was invented by the industry and hospital 
physicians – it doesn’t mean anything to patients. Comparing it to diabetes the 
difference is, that you have something more concrete to threaten people with – they 
become blind or get their legs chopped of like salami. With asthma you are just not 
feeling well. It looks too much like something we all have – you would also go to 
work, even if you had a headache or menstrual pains (cramps?). 
 
Though not trivial for individuals, asthma isn’t seen as difficult, but asking patients to take 
up the tools of “the industry and hospital physicians” participates in making it complicated. 
It assumes that the means of handling the illness are neutral and of equal importance to 
patients, GPs, specialists and industry as long as it assist in produce the shared goal: better 
control of asthma. But for this GP the tool is not neutral and it might make asthma into 
something more problematic and complicated than it has to be. Even if everyone has equal 
access to tools and information (though this is hardly the case here) it might not do any 
good. The monitoring and keying in of peak flow values are necessary for the proper 
functioning of the algorithms of the monitoring tool. Without these data the GP can’t follow 
guidelines in the form they are given here. Without these data the pharmaceutical company 
are even further from being able to monitor and secure their marked (though they are still 
not able to “mine” these data in a scientifically relevant way as of yet). These data might 
promise to be potent in linking these different actors giving them the possibility to act at a 
distance and producing shared interests, but when standing with the individual patient the 
GPs become hesitant in putting too much effort into the persuasion to make patients enter 
data. Asthma can be produced as peak flow readings and messages on a computer screen, 
but if it doesn’t produce other benefits than the avoidance of a potential “headache”, which 
you might already feel that you can get rid of by using medication, then peak flow and self 
monitoring will not add much value to the life lived with asthma. The patients that are 
reachable – qua Internet connections, previous compliant behavior, literacy etc. – may also 
be those that might need medical intervention the least, and will still demand a great deal of 
involvement from the GP introducing the tool to them in relation to encouraging them to 
use it.    
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Conclusion         
The dissemination of medical knowledge and standardized practices through technologically 
“powered”, materially embedded and distributed tools seems to be a utopia at best. The 
promised modesty of the linkmedica-tool, which was based on the notion of shared 
interests, common goals and socialmaterial practices that wasn’t there, was in the end 
gradually being experienced by the GPs I interviewed as an immodesty actually participating 
in producing differences in interests of patients, GP and pharmaceutical company. Rather 
than being the vehicle for producing more sameness, more order by black-boxing the 
categories of asthma, of the patient, of medical intervention, it actually opened up such 
categories, while trying to be fitted into already existing practices. Instead of producing more 
sameness and order, it actually introduced the GPs with more difference in terms of 
different diagnoses, different kinds of patients, different ways of intervening and 
(appropriate) zones of medical intervention.  
An often-stated lesson of technological innovation is that both practices and tool will have 
to change to make the tool part of practice. Tools do not change practices on their own 
from some kind of technological determinism, but have to be picked up and translated while 
also participating in translating the actors and practices that it becomes engaged in 
(Timmermanns & Berg, forthcoming). Though designers are often very aware of the many 
variables that might counter the script of their particular tool, they often see these as stones 
on the way rather than problems being produced though their particular innovation. A new 
order doesn’t just replace earlier states of disorder or idiosyncrasies, but participate in 
reconfigurations of practices and redistribution of sources of contingencies (Berg, 1998). 
Furthermore a new order that tries to align, tame or make singular too many entities and 
agents at once, may be confronted with equally big numbers of disorders having to be dealt 
with in practice.  
Asthma treatment and other areas of chronic disease may very well be appropriate areas of 
technological intervention, and thinking in ways of giving GPs and patients new possibilities 
of engaging in more cooperative ways of treatment still seems to be of great importance. 
However, what may be needed is a greater appreciation of the practices in which these 
changes are to take place, and more open discussions related to the consequences of such 
reconfigurations and redistribution of disorder and contingencies. For one thing, connecting 
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the work in to clinic to the everyday lives of people, who continuously or only occasionally 
are experiencing problems with asthma, in this new and different way inevitably introduces 
or strengthens otherwise distant complexities as in some way relevant and manageable for 
medicine. Instead of presuming common interests and singularity one might rather start out 
asking whether the creation of new complexities (in the work of primary care and in the lives 
of people with asthma) is a good trade-off for the benefits achieved.    
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